News
In patients with type 2 diabetes, GLP-1 agonist therapy is associated with decreased risk for AF recurrence following ablation for AF.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback